Bowen's disease and Bowenoid papulosis of the vulva.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7789604)

Published in Int J Gynaecol Obstet on February 01, 1995

Authors

D Y Chang, M Y Wu, S C Huang

Articles by these authors

(truncated to the top 100)

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85

The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24

Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr (1979) 3.18

The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17

Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol (1980) 3.12

Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry (2001) 2.67

Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn (1987) 2.03

[Intestinal parasite and Clonorchis sinensis infection among the inhabitants in the upper stream of Taechong Dam, Kumgang (River)]. Korean J Parasitol (1994) 1.89

Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab (1998) 1.84

Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med (1992) 1.83

Repair of single base-pair transversion mismatches of Escherichia coli in vitro: correction of certain A/G mismatches is independent of dam methylation and host mutHLS gene functions. Genetics (1988) 1.80

13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation (1989) 1.77

A novel nucleotide excision repair for the conversion of an A/G mismatch to C/G base pair in E. coli. Cell (1988) 1.76

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci (2001) 1.73

Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Mov Disord (2001) 1.68

Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr (1995) 1.67

Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood (2001) 1.66

Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol (1998) 1.63

Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. J Cereb Blood Flow Metab (1986) 1.62

Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys (2001) 1.61

Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med (1992) 1.59

Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation (1995) 1.54

A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med (1993) 1.53

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med (1987) 1.51

Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res (1999) 1.51

The SNRPN promoter is not required for genomic imprinting of the Prader-Willi/Angelman domain in mice. Nat Genet (2001) 1.50

A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res (2001) 1.49

Prediction of residual neoplasia based on histopathology and margin status of conization specimens. Gynecol Oncol (1996) 1.47

Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. Fertil Steril (1997) 1.46

A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. J Am Coll Cardiol (1991) 1.46

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry (2009) 1.44

Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. J Comput Assist Tomogr (1979) 1.41

Results of subtotal thyroidectomy for Graves' disease. Thyroid (1999) 1.41

Characterization of the interaction between protein 4.1R and ZO-2. A possible link between the tight junction and the actin cytoskeleton. J Biol Chem (2000) 1.40

Patient-controlled analgesia--the value of a background infusion. Anaesth Intensive Care (1990) 1.39

Genetic regulation of the catalase developmental program in maize scutellum: Identification of a temporal regulatory gene. Proc Natl Acad Sci U S A (1980) 1.39

Two nicking enzyme systems specific for mismatch-containing DNA in nuclear extracts from human cells. J Biol Chem (1991) 1.39

Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. J Nucl Med (1991) 1.38

Study of cerebral function with positron computed tomography. J Cereb Blood Flow Metab (1982) 1.37

Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med (1995) 1.36

Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol (2001) 1.36

N-13 ammonia as an indicator of myocardial blood flow. Circulation (1981) 1.35

Brain structural mapping using a novel hybrid implicit/explicit framework based on the level-set method. Neuroimage (2005) 1.33

Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation (1983) 1.32

A nonerythroid isoform of protein 4.1R interacts with the nuclear mitotic apparatus (NuMA) protein. J Cell Biol (1999) 1.32

Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury. J Neurotrauma (2000) 1.30

Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med (1989) 1.30

Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. Int J Biomed Comput (1993) 1.27

Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol (2001) 1.26

Lipoleiomyoma of the uterus. Int J Gynaecol Obstet (1999) 1.26

Parent influences on adolescent peer orientation and substance use: the interface of parenting practices and values. Child Dev (1998) 1.23

Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry (2001) 1.23

The nucleotide sequence of tobacco rattle virus RNA-2 (CAM strain). Nucleic Acids Res (1985) 1.21

An unbiased parametric imaging algorithm for nonuniformly sampled biomedical system parameter estimation. IEEE Trans Med Imaging (1996) 1.20

Nanobubbles in solid-state nanopores. Phys Rev Lett (2006) 1.20

Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation (1996) 1.19

The RNA polymerase III terminator used by a B1-Alu element can modulate 3' processing of the intermediate RNA product. Mol Cell Biol (1992) 1.18

ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. J Nucl Med (1978) 1.17

Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med (1982) 1.17

Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys (1980) 1.16

Structure and function of a chloroplast DNA replication origin of Chlamydomonas reinhardtii. Proc Natl Acad Sci U S A (1986) 1.16

Human signal recognition particle (SRP) Alu-associated protein also binds Alu interspersed repeat sequence RNAs. Characterization of human SRP9. J Biol Chem (1995) 1.15

Intraoperative crystallization on the intraocular lens surface. Am J Ophthalmol (1998) 1.15

Quantitation in positron emission computed tomography: 4. Effect of accidental coincidences. J Comput Assist Tomogr (1981) 1.13

Effect of positron range on spatial resolution. J Nucl Med (1975) 1.13

Metabolic recovery following human traumatic brain injury based on FDG-PET: time course and relationship to neurological disability. J Head Trauma Rehabil (2001) 1.13

Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer (1999) 1.12

Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation (1992) 1.12

Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. J Nucl Med (1979) 1.11

Tissue-specific alternative splicing of protein 4.1 inserts an exon necessary for formation of the ternary complex with erythrocyte spectrin and F-actin. Blood (1993) 1.10

The effects of measurement errors in the plasma radioactivity curve on parameter estimation in positron emission tomography. Phys Med Biol (1991) 1.10

Quantitation in positron emission computed tomography: 6. effect of nonuniform resolution. J Comput Assist Tomogr (1982) 1.10

A noninvasive positron computed tomography technique using oxygen-15--labeled water for the evaluation of neurobehavioral task batteries. J Cereb Blood Flow Metab (1985) 1.09

Validation of PET-acquired input functions for cardiac studies. J Nucl Med (1988) 1.08

Derivation of input function from FDG-PET studies in small hearts. J Nucl Med (1996) 1.08

Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch Neurol (1990) 1.07

Whole body skeletal imaging with [18F]fluoride ion and PET. J Comput Assist Tomogr (1993) 1.07

Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res (1997) 1.06

Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. J Comput Assist Tomogr (1992) 1.05

The decline in human Alu retroposition was accompanied by an asymmetric decrease in SRP9/14 binding to dimeric Alu RNA and increased expression of small cytoplasmic Alu RNA. Mol Cell Biol (1997) 1.03

Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol (1979) 1.02

Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. J Nucl Med (1994) 1.02

Movements of cultured corneal epithelial cells and stromal fibroblasts in electric fields. Invest Ophthalmol Vis Sci (1990) 1.02

Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med (1991) 1.02

Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys (1985) 1.01

Molecular cloning of suppressor of sable, a Drosophila melanogaster transposon-mediated suppressor. Mol Cell Biol (1986) 1.01

Validation of a model for [1-11C]acetate as a tracer of cardiac oxidative metabolism. Am J Physiol (1994) 1.01

Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome. Arch Neurol (2011) 1.01

A study on statistically reliable and computationally efficient algorithms for generating local cerebral blood flow parametric images with positron emission tomography. IEEE Trans Med Imaging (1993) 1.00

Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med (1998) 1.00

Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg (1997) 1.00

Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med (1982) 1.00

Weighted integration method for local cerebral blood flow measurements with positron emission tomography. J Cereb Blood Flow Metab (1986) 1.00

Preliminary result of an algorithm to select proper ventricular assist devices for high-risk patients with extracorporeal membrane oxygenation support. J Heart Lung Transplant (2001) 1.00

Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia. J Med Microbiol (1997) 0.99

Asynchronous regulation of splicing events within protein 4.1 pre-mRNA during erythroid differentiation. Blood (1996) 0.99

Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med (1993) 0.99

Acute necrotizing encephalopathy of childhood. Chang Gung Med J (2001) 0.98

An investigation of a double-tracer technique for positron computerized tomography. J Nucl Med (1982) 0.98